Answers are grounded in this paper and cite their sources.
The purpose of the present study was to clarify the differences in the bioavailability and tissue accumulation efficiency between (all- E )- and ( Z )-astaxanthin. Astaxanthin with a high proportion of the Z -isomer (especially rich in the 9 Z - and 13 Z -isomers) was prepared from (all- E )-astaxanthin by thermal treatment and solid–liquid separation. The all- E -isomer- or Z -isomer-rich diet was fed to male rats for 2 weeks. After the feeding period, blood and tissue samples were collected, and their astaxanthin levels were evaluated. The Z -isomer-rich astaxanthin diet resulted in higher levels of astaxanthin in blood and many tissues (in particular, skin, lung, prostate, and eye) compared to the all- E -isomer-rich diet. Moreover, the Z -isomer-rich diet enhanced the level of the 13 Z -isomer in blood and tissues rather than that of the 9 Z -isomer. These results strongly supported that astaxanthin Z -isomers have greater bioavailability and tissue accumulation efficiency than the all- E -isomer. Moreover, (13 Z )-astaxanthin would have higher bioavailability and tissue accumulation than the other isomers.
No takes yet. Share an insight, caveat, or question.
Honda et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: